AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 11961019 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified peritoneal dialysis prescription to achieve a peritoneal creatinine clearance (pCrCl) of 60 L/wk per 1.73 m(2)
Number of subjects: 965
Study 11961019 — intervention group
Group type: COMPARATOR
Intervention: Standard PD prescription (4 daily exchanges with 2 L of standard PD solution)
Number of subjects: 965
Study 9405732 — intervention group
Group type: EXPERIMENTAL
Intervention: Growth hormone (GH) replacement therapy
Number of subjects: 19
Study 7806922 — intervention group
Group type: EXPERIMENTAL
Intervention: Hot water immersion (39.5 degrees C) for 2 hours
Number of subjects: 8
Study 7806922 — intervention group
Group type: COMPARATOR
Intervention: Thermoneutral water immersion (34.5 degrees C) for 2 hours
Number of subjects: 8
Study 2668462 — intervention group
Group type: EXPERIMENTAL
Intervention: Ambulatory blood pressure monitoring
Number of subjects: 75
Study 817856 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol 160 mg/day
Number of subjects: 15
Study 817856 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol 320 mg/day
Number of subjects: 15
Study 817856 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 817856 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous isoproterenol
Number of subjects: 15
Study 31220863 — intervention group
Group type: EXPERIMENTAL
Intervention: MUL CM
Number of subjects: 216
Study 31220863 — intervention group
Group type: EXPERIMENTAL
Intervention: MUL RSM
Number of subjects: 216
Study 31220863 — intervention group
Group type: COMPARATOR
Intervention: SKR GM
Number of subjects: 216
Study 31220863 — intervention group
Group type: EXPERIMENTAL
Intervention: MUL SFM
Number of subjects: 216
Study 27904912 — intervention group
Group type: EXPERIMENTAL
Intervention: Radial extracorporeal shock wave therapy (rESWT) - 3 sessions, each one week apart, 2,000 rESWT impulses per session, positive energy flux density 0.10-0.16 mJ/mm2
Number of subjects: 105
Study 27904912 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 105
Study 26008634 — intervention group
Group type: EXPERIMENTAL
Intervention: β‐alanine (3.2 g/day)
Number of subjects: 24
Study 26008634 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 24
Study 26008634 — intervention group
Group type: EXPERIMENTAL
Intervention: SIT (Sprint Interval Training)
Number of subjects: 24
Study 22648526 — intervention group
Group type: EXPERIMENTAL
Intervention: H60% (60% maximal oxygen uptake)
Number of subjects: 10
Study 22648526 — intervention group
Group type: EXPERIMENTAL
Intervention: H75% (75% maximal oxygen uptake)
Number of subjects: 10
Study 22648526 — intervention group
Group type: COMPARATOR
Intervention: C60% (60% maximal oxygen uptake in 18 °C)
Number of subjects: 10
Study 21849519 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental infection with human H3N2 influenza A virus (IAV) in a commercial swine breed.
Number of subjects: 0
Study 21849519 — intervention group
Group type: EXPERIMENTAL
Intervention: Sera from experimentally inoculated animals.
Number of subjects: 0
Study 19487194 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (dopamine agonist)
Number of subjects: 0
Study 19487194 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study 16869202 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical application of placental-extract gel
Number of subjects: 120
Study 16869202 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical application of placental-extract cream
Number of subjects: 120
Study 15190718 — intervention group
Group type: EXPERIMENTAL
Intervention: Convex hull hypothesis
Number of subjects: 0
Study 15190718 — intervention group
Group type: COMPARATOR
Intervention: Crossing avoidance hypothesis
Number of subjects: 0
Study 10770191 — intervention group
Group type: EXPERIMENTAL
Intervention: IGF‐I/IGFBP‐3 (2 mg/kg‐day) by continuous sc infusion for 2 weeks
Number of subjects: 12
Study 10770191 — intervention group
Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 12
Study 9432523 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (0.3 mg/kg morning dose)
Number of subjects: 30
Study 9432523 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 9432523 — intervention group
Group type: COMPARATOR
Intervention: Antiepileptic drugs (AEDs) only
Number of subjects: 30
Study 8260309 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous subcutaneous infusion (CSCI) of morphine 30 micrograms kg‐1 h‐1 after a bolus of 0.1 mg kg‐1 i.v. at the end of the operation
Number of subjects: 40
Study 8260309 — intervention group
Group type: COMPARATOR
Intervention: Discontinuous extradural injection of morphine 4 mg at 0, 2, 10 and 18 h after operation
Number of subjects: 40
Study 8260309 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 40
Study 3856545 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostaglandin F2 alpha (200 micrograms topically applied)
Number of subjects: 18
Study 3856545 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 18
Study 30827716 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical therapy (PT) on postoperative day 0 (POD 0)
Number of subjects: 394
Study 30827716 — intervention group
Group type: COMPARATOR
Intervention: Physical therapy (PT) on postoperative day 1 (POD 1)
Number of subjects: 394
Study 29539651 — intervention group
Group type: EXPERIMENTAL
Intervention: Linked color imaging (LCI)
Number of subjects: 600
Study 29539651 — intervention group
Group type: COMPARATOR
Intervention: High definition white-light imaging (WLI)
Number of subjects: 600
Study 27894470 — intervention group
Group type: EXPERIMENTAL
Intervention: Sham acupuncture point stimulation with positive verbal suggestions
Number of subjects: 21
Study 27894470 — intervention group
Group type: COMPARATOR
Intervention: Control condition (natural history)
Number of subjects: 21
Study 25438913 — intervention group
Group type: EXPERIMENTAL
Intervention: Younger patients (<75 years)
Number of subjects: 1264
Study 25438913 — intervention group
Group type: COMPARATOR
Intervention: Older patients (≥75 years)
Number of subjects: 1264
Study 25438913 — intervention group
Group type: EXPERIMENTAL
Intervention: Each increasing decade of life
Number of subjects: 1264
Study 22117841 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous bone (AB) chips
Number of subjects: 92
Study 22117841 — intervention group
Group type: EXPERIMENTAL
Intervention: Ossix membrane (OM)
Number of subjects: 92
Study 22117841 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of AB chips and OM
Number of subjects: 92
Study 22117841 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 92
Study 20222844 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone therapy (HT)
Number of subjects: 139
Study 20222844 — intervention group
Group type: COMPARATOR
Intervention: No hormone therapy (control group)
Number of subjects: 139
Study 18562790 — intervention group
Group type: EXPERIMENTAL
Intervention: Antioxidant supplementation (152 mg vitamin C/day and 50 mg vitamin E/day)
Number of subjects: 14
Study 18562790 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 16151355 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified liberatory maneuver (LM)
Number of subjects: 124
Study 16151355 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified canalith repositioning maneuver (CRP)
Number of subjects: 124
Study 16151355 — intervention group
Group type: EXPERIMENTAL
Intervention: Brandt and Daroff's exercise
Number of subjects: 124
Study 16151355 — intervention group
Group type: COMPARATOR
Intervention: Vertigo habituation exercises
Number of subjects: 124
Study 16151355 — intervention group
Group type: COMPARATOR
Intervention: Sham maneuver
Number of subjects: 124
Study 12469707 — intervention group
Group type: EXPERIMENTAL
Intervention: Various doses of estrogen (0.3 mg CEE, 0.25 mg 17beta‐estradiol, transdermal patches delivering 20 microg 17beta‐estradiol, intranasal methods delivering 100-400 microg 17beta‐estradiol, 0.625 mg CEE, 0.5 mg 17beta‐estradiol) with or without progestogen.
Number of subjects: 0
Study 12469707 — intervention group
Group type: EXPERIMENTAL
Intervention: Progestogen addition to estrogen therapy in women with intact uterus.
Number of subjects: 0
Study 10943107 — intervention group
Group type: COMPARATOR
Intervention: Statins
Number of subjects: 450000
Study 9168439 — intervention group
Group type: EXPERIMENTAL
Intervention: lenograstim 5 micrograms/kg/day (n = 82)
Number of subjects: 162
Study 9168439 — intervention group
Group type: COMPARATOR
Intervention: placebo (n = 80)
Number of subjects: 162
Study 8460344 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular (IM) vaccination of recombinant HB vaccine
Number of subjects: 83
Study 8460344 — intervention group
Group type: COMPARATOR
Intervention: Intradermal (ID) vaccination of recombinant HB vaccine
Number of subjects: 83
Study 8460344 — intervention group
Group type: EXPERIMENTAL
Intervention: IM booster dose given 10 months after the third injection
Number of subjects: 83
Study 8460344 — intervention group
Group type: EXPERIMENTAL
Intervention: Age > 30 years
Number of subjects: 83
Study 3895410 — intervention group
Group type: EXPERIMENTAL
Intervention: Emepronium carrageenate (EC) 500 mg
Number of subjects: 18
Study 3895410 — intervention group
Group type: EXPERIMENTAL
Intervention: Emepronium carrageenate (EC) 1000 mg
Number of subjects: 18
Study 3895410 — intervention group
Group type: EXPERIMENTAL
Intervention: Emepronium carrageenate (EC)
Number of subjects: 18
Study 3895410 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 30823909 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital lifestyle intervention
Number of subjects: 3000
Study 30823909 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital and face-to-face group lifestyle intervention
Number of subjects: 3000
Study 30823909 — intervention group
Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 3000
Study 29533946 — intervention group
Group type: EXPERIMENTAL
Intervention: Revascularization (successful revascularization)
Number of subjects: 65
Study 29533946 — intervention group
Group type: EXPERIMENTAL
Intervention: Low baseline ADCr (<64%) with successful revascularization
Number of subjects: 65
Study 29533946 — intervention group
Group type: EXPERIMENTAL
Intervention: Revascularization (flow reconstitution)
Number of subjects: 65
Study 27173472 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight loss program
Number of subjects: 143
Study 24950995 — intervention group
Group type: EXPERIMENTAL
Intervention: Augmented feedback intervention
Number of subjects: 28
Study 24950995 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 28
Study 21783298 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 mg of meloxicam IM
Number of subjects: 30
Study 21783298 — intervention group
Group type: COMPARATOR
Intervention: 50 mg of tramadol IM
Number of subjects: 30
Study 20738456 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.05% chlorhexidine/herbal extract combination
Number of subjects: 45
Study 20738456 — intervention group
Group type: COMPARATOR
Intervention: 0.1% chlorhexidine solution
Number of subjects: 45
Study 18031323 — intervention group
Group type: EXPERIMENTAL
Intervention: High-carbohydrate meal (CHO)
Number of subjects: 10
Study 18031323 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fat meal (FAT)
Number of subjects: 10
Study 18031323 — intervention group
Group type: COMPARATOR
Intervention: Continued fast (FAST)
Number of subjects: 10
Study 16953808 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-component fall-prevention efforts
Number of subjects: 0
Study 16953808 — intervention group
Group type: COMPARATOR
Intervention: Physical activity
Number of subjects: 0
Study 16953808 — intervention group
Group type: COMPARATOR
Intervention: Depression screening and treatment
Number of subjects: 0
Study 14971519 — intervention group
Group type: EXPERIMENTAL
Intervention: Intradermal vaccination at a dose of 0.1 ml, 2 microg, administered at 5 positions, 4 vaccinations at months 0, 1, 2, and 6 (M0, M1, M2, M6)
Number of subjects: 2
Study 14971519 — intervention group
Group type: COMPARATOR
Intervention: Intramuscular vaccination at a dose of 1.0 ml, 20 microg, administered at 2 positions, 4 vaccinations at months 0, 1, 2, and 6 (M0, M1, M2, M6)
Number of subjects: 2
Study 14971519 — intervention group
Group type: EXPERIMENTAL
Intervention: Intradermal vaccination
Number of subjects: 2
Study 14971519 — intervention group
Group type: COMPARATOR
Intervention: Intramuscular vaccination
Number of subjects: 2
Study 10812328 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E intervention in the prevention of cataract and age-related maculopathy
Number of subjects: 1204
Study 10812328 — intervention group
Group type: COMPARATOR
Intervention: Electoral roll mail-out
Number of subjects: 1204
Study 10812328 — intervention group
Group type: COMPARATOR
Intervention: Newspaper advertising
Number of subjects: 1204
Study 10812328 — intervention group
Group type: COMPARATOR
Intervention: Radio advertising, approaches to community groups, approaches via general practices
Number of subjects: 1204
Study 8712886 — intervention group
Group type: EXPERIMENTAL
Intervention: IA guanethidine 20 mg
Number of subjects: 18
Study 8712886 — intervention group
Group type: COMPARATOR
Intervention: IA saline (placebo)
Number of subjects: 18
Study 31721892 — intervention group
Group type: EXPERIMENTAL
Intervention: tDCS
Number of subjects: 195
Study 31721892 — intervention group
Group type: EXPERIMENTAL
Intervention: escitalopram
Number of subjects: 195
Study 31721892 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 195
Study 31721892 — intervention group
Group type: COMPARATOR
Intervention: tDCS vs. placebo
Number of subjects: 195
Study 31721892 — intervention group
Group type: COMPARATOR
Intervention: tDCS vs. escitalopram
Number of subjects: 195
Study 31721892 — intervention group
Group type: COMPARATOR
Intervention: escitalopram vs. placebo
Number of subjects: 195
Study 29443905 — intervention group
Group type: EXPERIMENTAL
Intervention: Military body armour (MBA: 6.4 kg)
Number of subjects: 10
Study 29443905 — intervention group
Group type: EXPERIMENTAL
Intervention: Law-enforcement body armour (LEBA: 2.1 kg)
Number of subjects: 10
Study 29443905 — intervention group
Group type: EXPERIMENTAL
Intervention: Both body armours
Number of subjects: 10
Study 29071931 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture + fire dragon moxibustion
Number of subjects: 90
Study 29071931 — intervention group
Group type: COMPARATOR
Intervention: Acupuncture (control)
Number of subjects: 90
Study 24122481 — intervention group
Group type: EXPERIMENTAL
Intervention: Media Heroes cyberbullying prevention program
Number of subjects: 593
Study 24122481 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 593
Study 22337211 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical therapy (education, muscle stretching, exercises, homework for nine treatments in 6 weeks)
Number of subjects: 53
Study 22337211 — intervention group
Group type: COMPARATOR
Intervention: Control group (education on evaluation days only)
Number of subjects: 53
Study 22184305 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefazolin (2 g) administered before skin incision
Number of subjects: 1112
Study 22184305 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefazolin (2 g) administered after umbilical cord clamping
Number of subjects: 1112
Study 22184305 — intervention group
Group type: COMPARATOR
Intervention: Placebo administered before skin incision
Number of subjects: 1112
Study 17971285 — intervention group
Group type: EXPERIMENTAL
Intervention: Risedronate 150 mg (50 mg doses on 3 consecutive days) monthly for 6 months
Number of subjects: 150
Study 17971285 — intervention group
Group type: EXPERIMENTAL
Intervention: Loading dose of risedronate 15 mg daily for 1 month followed by 150 mg (50 mg doses on 3 consecutive days) monthly for 5 months
Number of subjects: 150
Study 17971285 — intervention group
Group type: COMPARATOR
Intervention: Risedronate 5 mg daily for 6 months
Number of subjects: 150
Study 16145231 — intervention group
Group type: EXPERIMENTAL
Intervention: Clo‐Sur PAD nonwoven hydrophilic wound dressing (HWD)
Number of subjects: 80
Study 16145231 — intervention group
Group type: COMPARATOR
Intervention: RadiStop compression device (CD)
Number of subjects: 80
Study 11865830 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentoxifylline (PXF) 1800 mg/day
Number of subjects: 60
Study 11865830 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 10539744 — intervention group
Group type: EXPERIMENTAL
Intervention: Solid-food diet (SFD)
Number of subjects: 21
Study 10539744 — intervention group
Group type: COMPARATOR
Intervention: Liquid-formula diet (LFD)
Number of subjects: 21
Study 7592212 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled methacholine (intervention)
Number of subjects: 7
Study 7592212 — intervention group
Group type: COMPARATOR
Intervention: Raw (1.3), RLq (1.4), RL of double resting frequency (1.9), Rrs (1.7), smooth curve fit of Pm back extrapolated to valve closure (1.5) (baseline measurements)
Number of subjects: 7
Study 7592212 — intervention group
Group type: EXPERIMENTAL
Intervention: Rint methods (three methods of obtaining Rint)
Number of subjects: 7
Study 7592212 — intervention group
Group type: EXPERIMENTAL
Intervention: Rrs methods
Number of subjects: 7
Study 2089148 — intervention group
Group type: EXPERIMENTAL
Intervention: Flex-Foot
Number of subjects: 5
Study 2089148 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbon Copy II
Number of subjects: 5
Study 2089148 — intervention group
Group type: EXPERIMENTAL
Intervention: SEATTLE
Number of subjects: 5
Study 2089148 — intervention group
Group type: EXPERIMENTAL
Intervention: STEN
Number of subjects: 5
Study 2089148 — intervention group
Group type: COMPARATOR
Intervention: SACH foot
Number of subjects: 5
Study 105689 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbamazepine
Number of subjects: 23
Study 105689 — intervention group
Group type: COMPARATOR
Intervention: Phenytoin
Number of subjects: 23
Study 30383229 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute weight loss (mean, 7.2%)
Number of subjects: 80
Study 30383229 — intervention group
Group type: COMPARATOR
Intervention: Lean control group (n = 80)
Number of subjects: 80
Study 26648167 — intervention group
Group type: EXPERIMENTAL
Intervention: Female offenders with mental retardation
Number of subjects: 156
Study 26648167 — intervention group
Group type: COMPARATOR
Intervention: Male offenders with mental retardation
Number of subjects: 156
Study 26648167 — intervention group
Group type: COMPARATOR
Intervention: General assessment of severe mental disorder
Number of subjects: 156
Study 25554550 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline body temperature (mean 37.5°C, SD 1.1°C)
Number of subjects: 969
Study 25554550 — intervention group
Group type: EXPERIMENTAL
Intervention: Temperature groups (divided into 5 groups)
Number of subjects: 969
Study 23458204 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetaminophen (ACT)
Number of subjects: 12
Study 23458204 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 21629249 — intervention group
Group type: EXPERIMENTAL
Intervention: Quadrivalent HPV vaccine
Number of subjects: 3819
Study 21629249 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3819
Study 19520613 — intervention group
Group type: EXPERIMENTAL
Intervention: Memantine (20 mg per day)
Number of subjects: 72
Study 19520613 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study 16918855 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy Learners Asthma Initiative (HLAI) intervention
Number of subjects: 16
Study 16918855 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 16
Study 15327408 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline hemoglobin concentration (Hb) stratified by quartile: first quartile <11.3 g/dL
Number of subjects: 1513
Study 15327408 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline hemoglobin concentration (Hb) stratified by quartile: second quartile 11.3 to 12.5 g/dL
Number of subjects: 1513
Study 15327408 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline hemoglobin concentration (Hb) stratified by quartile: third quartile 12.6 to 13.8 g/dL
Number of subjects: 1513
Study 15327408 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemoglobin as a continuous variable
Number of subjects: 1513
Study 11154169 — intervention group
Group type: EXPERIMENTAL
Intervention: Lansoprazole
Number of subjects: 50
Study 11154169 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole
Number of subjects: 50
Study 11154169 — intervention group
Group type: EXPERIMENTAL
Intervention: Lansoprazole or Omeprazole with antibiotics
Number of subjects: 50
Study 11154169 — intervention group
Group type: EXPERIMENTAL
Intervention: Serology monitoring
Number of subjects: 50
Study 9286194 — intervention group
Group type: EXPERIMENTAL
Intervention: Assertive community treatment
Number of subjects: 77
Study 8403909 — intervention group
Group type: EXPERIMENTAL
Intervention: NORPLANT II contraceptive implant
Number of subjects: 1466
Study 3520426 — intervention group
Group type: EXPERIMENTAL
Intervention: Monthly maintenance therapy
Number of subjects: 0
Study 3520426 — intervention group
Group type: EXPERIMENTAL
Intervention: Special type of immunotherapy
Number of subjects: 0
Study 29370744 — intervention group
Group type: EXPERIMENTAL
Intervention: IT-enabled intervention (website development, SMS, e-mail reminders, interactive help by mobile and landline phones)
Number of subjects: 0
Study 29370744 — intervention group
Group type: COMPARATOR
Intervention: Traditional nutrition education program (distributing pamphlets)
Number of subjects: 0
Study 27774073 — intervention group
Group type: EXPERIMENTAL
Intervention: Group music therapy plus standard care (48 weekly sessions of 2 hours)
Number of subjects: 27
Study 27774073 — intervention group
Group type: COMPARATOR
Intervention: Standard care only
Number of subjects: 27
Study 25596790 — intervention group
Group type: EXPERIMENTAL
Intervention: Real-time ultrasound guidance
Number of subjects: 698
Study 25596790 — intervention group
Group type: COMPARATOR
Intervention: Palpation
Number of subjects: 698
Study 22961006 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteral supplementation of scGOS/lcFOS/pAOS
Number of subjects: 113
Study 22961006 — intervention group
Group type: COMPARATOR
Intervention: Antibiotics
Number of subjects: 113
Study 20862947 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture RCTs in China
Number of subjects: 0